and is a significant comorbid factor for other psychiatric and medical disorders. To date, no medication has been approved by the United States Food and Drug Administration for this indication. In the present Phase 2A, single-site, randomized, double-blind, placebo-controlled clinical trial, we determined the safety/tolerability and efficacy of a combination drug treatment, consisting of an immediate-release methylphenidate formulation (MPh-IR) and a novel formulation of the antiemetic ondansetron (Ond-PR2) ([MPh-IR + Ond-PR2]; ClinicalTrials.gov identifier: NCT01290276). Scores on selected behavioral rating scales and functional neuroimaging assessments under standard cue-reactivity and inhibitory control paradigms were used to compare the [MPh-IR + Ond-PR2] and placebo groups before and after two week treatment. All study procedures were conducted according to a protocol approved by the Duke University Health System Institutional Review Board. A total of 48 subjects meeting the Diagnostic and Statistical Manual of Mental Disorders Version 4 (DSM-4) criteria for "primary substance abuse" were screened and 30 qualifying subjects were randomized into one of the two treatment groups. Twenty eight subject completed the treatment and pre-and post-treatment assessments. No significant differences were observed between the two groups in the number of subjects experiencing adverse events, and no serious adverse events were observed or reported. In contrast to safety/ tolerability, [MPh-IR + Ond-PR2] treatment significantly reduced or tended to reduce selected rating score and neuroimaging measurements compared to placebo treatment. In summary, [MPh-IR + Ond-PR2] treatment was safe and well-tolerated by abstinent psychostimulant abusers, and the results to date indicate that this treatment might provide for an effective option for psychostimulant abuse treatment.
greatest magnitude of the standardized regression coefficient (.28) among all predictors, accounting for 39% of the total variance explained by the model. Conclusion: Our findings show that low self-control is a significant predictor of alcohol drinking, smoking, internet and smartphone addiction even when accounting for peer influences, parental attachment, and other statistical controls. Future research is needed about association between self control and deviant or addictive analogous behaviors. Keywords: Self control, internet addiction, smartphone addiction, adolescents, South Korea 
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Abstract
Objectives: This study aimed to survey public awareness of bipolar disorders in order to develop an appropriate education program for the general public, patients with bipolar disorders and caregivers. Methods: The authors created a questionnaire to survey public awareness of and attitude towards four illnesses: bipolar disorder (BD), schizophrenia (SPR), depressive disorder (DD), and diabetes mellitus (DM). The answers from a total number of 835 respondents living in the Seongnam city collected to compare awareness of BD to those of the other diseases. We also determined whether the answers from those who claimed to be familiar with BD were more knowledgeable about the disease than those who did not. Results: Ninety percent of the respondents answered that they knew of BD, which was slightly lower than those of SPR (91.1%), MDD (95.9%), and DM (96.1%). Twenty-five percent of the respondents answered that BD could recur after medication was stopped, was also lower than those of SPR (42%), DD (30%) and DM (59%). The level of social stigmatization of BD was similar to that of DD, milder than that of SPR and was higher than that in DM. Subjects who reported themselves to be familiar with BD preferred psychosocial treatment to the biological approach. Conclusion: Despite the relatively high prevalence of BD, the general public was not familiar with BD and had skewed knowledge about BD in Korean community. Services to provide correct knowledge and active participation of experts in creating educational programs will enhance public awareness of BD and will consequently help in early detection and timely interventions of BD. Key Words: Bipolar disorder, Awareness, Community, General public Abstract Alcoholism, which is defined by the recurring harmful use of alcohol despite its negative consequences, has lifetime prevalence of 10% and socially serious problem. Accumulating evidence indicate that alcoholism is often comorbid with schizophrenia and these diseases have common genetic risk factors and pathophysiology, such as hypoglutamatergic and hyperdopaminergic activities in the brain.
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By performing informatics analyses of genome-wide gene expression data, we previously revealed that brains of patients with schizophrenia have significant similarities with those of infants in their gene expression patterns in the hippocampus and prefrontal cortex (PFC).
Considering that the similarities between alcoholism and schizophrenia, we hypothesized that the brain cells of patients with alcoholism also show pseudo-immature phenotypes.
In this study, we compared genome-wide gene expression patterns in the hippocampus and PFC of patients with alcoholism with those in the corresponding regions of normal infants. Our informatics analyses demonstrated that the gene expression patterns of patients with alcoholism were significantly similar to those of infants in both brain regions. Interestingly, the genes which were changed in both of two groups were significantly overlapped with the genes regulated in the developmental course of parvalbumin-positive neurons.
These results suggest that pseudo-immaturity of the hippocampus and PFC could be one of the endophenotypes of alcoholism and might underlie the brain dysfunctions and behaviors of alcoholism.
CHILDHOOD & ADOLESCENT DISORDERS: PM334 -PM357 PM334
Effects of chronic tryptophan depletion on autism spectrum disorder like behaviors in serotonin transporter knockout and heterozygous mice 
